Clinical Leukemia Program Director
NYU Langone Health
Dr. Raoul Tibes is the Director of the Clinical Leukemia Program at NYU Langone Health’s Perlmutter Cancer Center.
He completed a hematology-oncology fellowship at MD Anderson Cancer Center, and has since dedicated his work to advancing clinical care of leukemia patients by bringing the latest science to patients.
After an AML Diagnosis, Knowing Your Risk Group is Important for Treatment
New Options For Acute Myeloid Leukemia (AML) Relapse: Combination Therapies with Gilteritinib
What is The Treatment For Acute Myeloid Leukemia (AML) Patients After Relapse: Gilteritinib And FLT3 Inhibitors
What Are The Options For Patients When Acute Myeloid Leukemia (AML) Returns?
The Benefits of Combination Drug Therapy Using Ventecolax for AML
Our newsletter – vital information, hope, and healing, delivered weekly.
Use this bar to access information about the steps in your cancer journey.
Please sign in to save videos. Don't have an account? Register
Username or email address *
Lost your password?
Not a member yet? Register now.